Financials
| Half-year Report | Jun. 18, 2024 |
| Annual Report & Accounts | Feb. 22, 2024 |
| Publication of FY22 Annual Report | Mar. 03, 2023 |
| Preliminary Results and Notice of AGM | Jan. 24, 2023 |
| Half-year Report | Jun. 28, 2022 |
| Final Results | Jan. 25, 2022 |
| Half-year Report | Jun. 15, 2021 |
Proxies
| Result of AGM | Mar. 27, 2024 |
| Result of AGM | Mar. 30, 2023 |
| Results of Annual General Meeting | Mar. 30, 2022 |
| Result of AGM | Mar. 24, 2021 |
| Results of Annual General Meeting | Mar. 20, 2020 |
| Publication of Annual Report and Notice of AGM | Jan. 23, 2020 |
| Results of Annual General Meeting | Mar. 14, 2019 |
Ownership Update
| Grant of Options | Jun. 21, 2024 |
| Holding(s) in Company | May. 10, 2024 |
| Holding(s) in Company | Apr. 25, 2024 |
| Holding(s) in Company | Apr. 11, 2024 |
| Holding(s) in Company | Apr. 10, 2024 |
| Holding(s) in Company | Apr. 09, 2024 |
| Holding(s) in Company | Apr. 09, 2024 |
Announcements
| OBD pursuing EpiSwitch as companion diagnostics | Jul. 25, 2024 |
| OBD's PSE test to be used in NCI trial | Jun. 06, 2024 |
| OBD develops multi-cancer diagnostic test for dogs | Jun. 04, 2024 |
| Notice of Results | May. 24, 2024 |
| OBD partners with Goodbody Clinic on PSE test | May. 23, 2024 |
| OBD partners with The London Clinic for PSE & CiRT | May. 21, 2024 |
| OBD and King's College London collaborate on RA | May. 16, 2024 |